Feasibility and 1‐Year outcomes of subintimal revascularization with supera^® stenting of long femoropopliteal occlusions in critical limb ischemia

Abstract

Subintimal revascularization with Supera stenting in CLI patients with long FP occlusions, is feasible and superior to validated efficacy performance goals. Larger multicenter studies are needed to validate the safety and efficacy of this novel alternative approach. © 2016 Wiley Periodicals, Inc.

Successful re-entry using the outback® elite catheter via retrograde popliteal access with IVUS guidance for femoropopliteal occlusion: a case report

“…In the present case, although the IVUS had passed through most of the CTO via the subintimal route, a sufficient minimal stent area was obtained by placing the stent after sufficient pre-dilatation and firm post-dilatation. The SUPERA® stent (Abbott Vascular, USA) is reportedly useful for subintimal recanalization (Palena et al 2017 ), but was not yet available in our institute at that time; this stent may be considered for use in the future.…”

SCAI consensus guidelines for device selection in femoral‐popliteal arterial interventions

“…A number of recent noncomparative studies have examined newer generation interwoven design BMS stents for treatment of FP disease, including in longer lesions, significant calcification, higher prevalence of CTOs, but not ISR lesions . Unfortunately, these studies have not included any comparative devices, so that limited conclusions about the relative effectiveness or comparative safety of the newer devices can be made.…”

SFA Intervention: Intraluminal or Subintimal?

“…However, as operators accumulated experience and adopted retrograde approaches from distal arteries and using re-entry devices, the technical success rate gradually improved ( Tables 1 and 2 ). 6) 7) 8) 9) 10) 11) 12) 13) 14) 15) 16) 17) 18) 19) 20) 21) 22) 23) 24) …”

“… 3) 6) 26) However, the introduction of self-expanding nitinol stents increased the 1-year SA patency rate from 65% to 80%. 15) 17) 19) 20) 22) 26) In a meta-analysis of 37 studies, the 1-year primary patency rate was 47.9% for SA without stent implantation, 61.6% for SA with provisional stenting, and 69.2% for SA with primary stenting. 26) …”